Greg Krempl to Oropharyngeal Neoplasms
This is a "connection" page, showing publications Greg Krempl has written about Oropharyngeal Neoplasms.
Connection Strength
0.458
-
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial. Cancer Res Commun. 2026 Mar 01; 6(3):706-713.
Score: 0.245
-
Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis. Lancet Oncol. 2024 Mar; 25(3):366-375.
Score: 0.213